Sage Therapeutics Stock Price (NASDAQ:SAGE)

Add to My Stocks
$83.61 $2.2 (2.7%) SAGE stock closing price Jul 21, 2017 (Closing)
Prev Close* : $81.41
Market Cap:
Day Low: $81.13
52 Week Low: $35.02
Open: $81.93
Volume: 429398
Day High: $84.25
52 Week High: $88.93

Latest Stock Market News

Latest Articles

Sage Therapeutics News - From Partners

SAGE Stockcharts

View SAGE PE ratio, PS ratio stocks charts and compare with peers.
SAGE Chart
Note: Compare Sage Therapeutics stock price history with the index and industry peers.

SAGE Industry Peers

Company Price Change (%)
Wuxi Pharmatech (WX)45.90.16 (0.35%)
Nektar Therapeutics (NKTR)22.240.07 (0.32%)
Marinus Pharma (MRNS)1.710.03 (1.79%)
Ligand Pharma (LGND)123.052.36 (1.96%)
Supernus Pharma (SUPN)42.20.1 (0.24%)
Zogenix (ZGNX)13.40.2 (1.47%)
Neurocrine Biosciences (NBIX)47.070.72 (1.51%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.350.25 (6.1%)
Ignyta (RXDX)9.30.5 (5.68%)
PTC Therapeutics (PTCT)21.441.1 (5.41%)
Xencor (XNCR)23.780.78 (3.39%)
Adamis Pharma (ADMP)4.80.15 (3.23%)
Enanta Pharma (ENTA)37.471.05 (2.88%)
Tetraphase Pharmaceuticals (TTPH)8.090.22 (2.8%)
Top gainers from Medical-Drugs industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Heron Therapeutics (HRTX)16.451.05 (6%)
ImmunoGen (IMGN)5.660.24 (4.07%)
CTI BioPharma (CTIC)3.410.12 (3.4%)
Catalyst Pharma (CPRX)2.950.1 (3.28%)
Pacira Pharma (PCRX)47.651.5 (3.05%)
BioCryst Pharma (BCRX)5.410.16 (2.87%)
GlycoMimetics (GLYC)11.50.33 (2.79%)
Top losers from Medical-Drugs industry
* As of Jul 22, 2017

SAGE Therapeutics Inc Stock News - Partner Headlines

Sage Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues-----
Net Income-158.98M-94.49M-33.81M-18.28M-9.63M
Total Operating Expense160.15M94.64M33.81M18.27M9.62M
view SAGE Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets404.53M189.01M129.66M8.53M-
Total Liabilities36.01M15.32M7.78M40.06M-
Shareholders Equity368.51M173.69M121.88M-31.53M-
view SAGE Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities17.47M7.24M4.07M0.59M-
Net Cash From (Used By) Operating Activities-118.67M-70.68M-27.04M-17.51M-
Increase (Decrease) In Prop Plant And Equipment-1.42M-0.19M-0.12M--
view SAGE Therapeutics Inc cashflow statement

Sage Therapeutics Stock Message Board

Sage Therapeutics stock price ended the last trading day at 83.61. Sage Therapeutics market capitalization is 3.04B and it represents the total market value of SAGE stock. Sage Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy SAGE stock than sell it, then Sage Therapeutics stock price goes up. Conversely, if more investors wanted to sell SAGE stock than buy it, there would be greater supply than demand, and the stock price would fall. 429398 SAGE shares were traded yesterday, and Sage Therapeutics stock chart shows that the SAGE stock quote hit a day high of 84.25 and day low of 81.13. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Sage Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.